Legend Biotech Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-296.8	-177	-518.3	-446.35	-403.58
Depreciation & Amortization	28.9	21.4	18.5	18.39	12.54
Other Amortization	-	-	-	-	1.38
Loss (Gain) From Sale of Assets	-	-	-	0.48	0.97
Asset Writedown & Restructuring Costs	-	4.4	-	-	-
Loss (Gain) From Sale of Investments	-	-	-0.7	-0.59	-
Stock-Based Compensation	64.6	68.9	47.7	34.34	20.16
Other Operating Activities	196.2	-80.1	132.2	5.24	8.15
Change in Accounts Receivable	-5.7	93.8	-99	50.32	24.59
Change in Inventory	-4.5	-17.2	-12.7	-13.89	0.05
Change in Accounts Payable	44.4	14.1	-50.2	72.45	1.81
Change in Unearned Revenue	-40	-49.7	100	6.18	0.08
Change in Other Net Operating Assets	-87.3	-22.6	-10.8	72.16	135.39
Operating Cash Flow	-100.2	-144	-393.3	-201.28	-198.47
Capital Expenditures	-28.6	-14.1	-20.1	-20.93	-42.2
Sale of Property, Plant & Equipment	-	-	-	-	0
Sale (Purchase) of Intangibles	-	-	-2.6	-1.35	-3.21
Investment in Securities	777	-784.6	204.6	-41.36	-147.88
Other Investing Activities	-38.8	-51.9	-89	-13.45	-1.71
Investing Cash Flow	709.6	-850.6	92.9	-77.09	-194.98
Long-Term Debt Repaid	-3.6	-4	-3.8	-2.6	-1.42
Total Debt Repaid	-3.6	-4	-3.8	-2.6	-1.42
Net Debt Issued (Repaid)	-3.6	-4	-3.8	-2.6	-1.42
Issuance of Common Stock	3.3	9.7	795.2	380.57	628.08
Financing Cash Flow	-0.3	5.7	791.4	377.98	626.66
Foreign Exchange Rate Adjustments	6.1	-2.1	0.7	-2.51	0.03
Net Cash Flow	615.2	-991	491.7	97.09	233.25
Free Cash Flow	-128.8	-158.1	-413.4	-222.21	-240.66
Free Cash Flow Margin	-12.52%	-25.20%	-145.00%	-189.91%	-349.67%
Free Cash Flow Per Share	-0.70	-0.86	-2.35	-1.40	-1.71
Cash Interest Paid	3.5	1.8	1.4	0.53	0.14
Cash Income Tax Paid	18.4	1.6	-0.3	-3.71	-0.56
Levered Free Cash Flow	-133.99	-40.55	-496.78	-202.66	-122.84
Unlevered Free Cash Flow	-120.61	-27.05	-483.16	-195.91	-122.28
Change in Working Capital	-93.1	18.4	-72.7	187.21	161.91

Source: S&P Global Market Intelligence. Standard template. Financial Sources.